Related Experiment Videos
Intraperitoneal insulin regimens and diabetic nephropathy
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association
|January 1, 1983
Summary
Intraperitoneal insulin therapy showed varied outcomes for diabetic nephropathy patients. Severe cases progressed, while moderate cases experienced stabilized or improved kidney function.
Area of Science:
- Nephrology
- Endocrinology
- Metabolic Diseases
Background:
- Diabetic nephropathy is a major complication of diabetes mellitus.
- Current treatments for diabetic nephropathy have limitations.
- Intraperitoneal insulin administration is an alternative therapeutic approach.
Purpose of the Study:
- To evaluate the efficacy of intraperitoneal insulin in patients with diabetic nephropathy.
- To assess the impact of intraperitoneal insulin on renal function in severe and moderate diabetic nephropathy.
Main Methods:
- Eleven patients with diabetic nephropathy (5 severe, 6 moderate) received intraperitoneal insulin via multiple injections.
- Renal function was monitored over 8 to 23 months.
Main Results:
- All five patients with severe diabetic nephropathy progressed to end-stage kidney disease.
- Five of six patients with moderate diabetic nephropathy showed stabilized renal function.
- Two patients with moderate diabetic nephropathy demonstrated possible improvement in renal function.
Conclusions:
- Intraperitoneal insulin therapy may not halt the progression of severe diabetic nephropathy.
- Intraperitoneal insulin administration shows potential for stabilizing or improving renal function in moderate diabetic nephropathy.
- Further research is warranted to explore the long-term effects and optimal use of intraperitoneal insulin in diabetic nephropathy.